|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HLA-DQ Typing for Narcolepsy
Test Code12342
CPT Codes
81383
Preferred Specimen
5 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
3 mL
Other Acceptable Specimens
Whole blood collected in: Sodium heparin (green-top) tube, EDTA (pink-top) tube, EDTA (royal blue-top) tube, or sodium citrate (light blue-top) tube
Instructions
If submitted with any other tests, please submit separate tube for this test. Do not open tube or split sample. Shipping refrigerated is acceptable.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable
Refrigerated: 7 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received frozen • Clotted
Methodology
Polymerase Chain Reaction Amplification • Sequence Specific Oligonucleotide Probes
Setup Schedule
Set up: Daily; Report available: 8 days
Reference Range
See Laboratory Report
Clinical Significance
The HLA-DQB1*06:02 is strongly associated with narcolepsy, a neurological condition associated with excessive daytime sleepiness, cataplexy, and other nighttime sleep disorders. Presence of HLA-DQB1*06:02 by itself is not diagnostic. It is used along with clinical history and sleep studies in the diagnosis of narcolepsy. Narcolepsy is associated with HLA DR15 (DR2) and DQB1*0602. DQB1*0602 was found to be a more sensitive marker for narcolepsy than DRB1*15 across all ethnic groups. DQB1*0602 frequency was strikingly higher in patients with cataplexy versus patients without cataplexy (76.1% in 421 patients versus 40.9% in 88 patients).
Reference:
E Mignot, et al. Sleep.1997 Nov;20(11):1012-20
Reference:
E Mignot, et al. Sleep.1997 Nov;20(11):1012-20